Hydrophobic deep eutectic solvent (HDES) as oil phase in lipid-based drug formulations
Language English Country Netherlands Media print-electronic
Document type Journal Article
PubMed
38964488
DOI
10.1016/j.ijpharm.2024.124418
PII: S0378-5173(24)00652-5
Knihovny.cz E-resources
- Keywords
- Advanced formulation(s), Deep eutectic solvent(s), Eutectic(s), Lipid-based formulation(s), Novel pharmaceutic(s), Poorly soluble drug(s),
- MeSH
- Chemistry, Pharmaceutical methods MeSH
- Hydrophobic and Hydrophilic Interactions * MeSH
- Lauric Acids chemistry MeSH
- Lipids * chemistry MeSH
- Oils chemistry MeSH
- Polysorbates chemistry MeSH
- Surface-Active Agents * chemistry MeSH
- Drug Compounding * methods MeSH
- Solvents * chemistry MeSH
- Solubility * MeSH
- Molecular Dynamics Simulation * MeSH
- Sulfonamides chemistry administration & dosage MeSH
- Drug Liberation * MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Lauric Acids MeSH
- lauric acid MeSH Browser
- Lipids * MeSH
- Oils MeSH
- Polysorbates MeSH
- Surface-Active Agents * MeSH
- Solvents * MeSH
- Sulfonamides MeSH
There is increasing pharmaceutical interest in deep eutectic solvents not only as a green alternative to organic solvents in drug manufacturing, but also as liquid formulation for drug delivery. The present work introduces a hydrophobic deep eutectic solvent (HDES) to the field of lipid-based formulations (LBF). Phase behavior of a mixture with 2:1 M ratio of decanoic- to dodecanoic acid was studied experimentally and described by thermodynamic modelling. Venetoclax was selected as a hydrophobic model drug and studied by atomistic molecular dynamics simulations of the mixtures. As a result, valuable molecular insights were gained into the interaction networks between the different components. Moreover, experimentally the HDES showed greatly enhanced drug solubilization compared to conventional glyceride-based vehicles, but aqueous dispersion behavior was limited. Hence surfactants were studied for their ability to improve aqueous dispersion and addition of Tween 80 resulted in lowest droplet sizes and high in vitro drug release. In conclusion, the combination of HDES with surfactant(s) provides a novel LBF with high pharmaceutical potential. However, the components must be finely balanced to keep the integrity of the solubilizing HDES, while enabling sufficient dispersion and drug release.
References provided by Crossref.org